{"id":5631,"date":"2008-07-05T14:55:00","date_gmt":"2008-07-05T14:55:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5631"},"modified":"2021-07-09T11:18:04","modified_gmt":"2021-07-09T11:18:04","slug":"partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/","title":{"rendered":"Partial remission of refractory RA after Adacolumn cytapheresis: a case report"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Bazzichi+L&amp;cauthor_id=17684748\">L Bazzichi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17684748\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Giuliano+T&amp;cauthor_id=17684748\">T Giuliano<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Rossi+A&amp;cauthor_id=17684748\">A Rossi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mazzoni+A&amp;cauthor_id=17684748\">A Mazzoni<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Grazzini+T&amp;cauthor_id=17684748\">T Grazzini<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=De+Feo+F&amp;cauthor_id=17684748\">F De Feo<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Giacomelli+C&amp;cauthor_id=17684748\">C Giacomelli<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Scatena+F&amp;cauthor_id=17684748\">F Scatena<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Bombardieri+S&amp;cauthor_id=17684748\">S Bombardieri<\/a>, Rheumatol Int. 2008 Jan;28(3):295-7.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>We report on a female case of rheumatoid arthritis (RA) with hepatitis C virus comorbidity. The patient was treated once weekly over ten consecutive weeks with Adacolumn device. Clinical assessment and HCV-RNA concentration were monitored at weeks-1, 4, 9, 14 and during follow-up over 6 months. At the end of the treatment: the number of tender and swollen joints, patient&#8217;s global assessment of disease activity (VAS), physician&#8217;s VAS, C-reactive protein (CRP) decreased, respectively; ACR response was &gt;20. This improvement was maintained for over 2 months. At week 38, the patient was re-treated achieving again an ACR response &gt;20.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17684748\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/17684748\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>L Bazzichi&nbsp;1,&nbsp;T Giuliano,&nbsp;A Rossi,&nbsp;A Mazzoni,&nbsp;T Grazzini,&nbsp;F De Feo,&nbsp;C Giacomelli,&nbsp;F Scatena,&nbsp;S Bombardieri, Rheumatol Int. 2008 Jan;28(3):295-7. We report on a female case of rheumatoid arthritis (RA) with hepatitis C virus comorbidity. The patient was treated once weekly over ten consecutive weeks with Adacolumn device. Clinical assessment and HCV-RNA concentration were monitored at weeks-1, 4, 9, 14 [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[336],"class_list":["post-5631","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-rheumatology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Partial remission of refractory RA after Adacolumn cytapheresis: a case report - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Partial remission of refractory RA after Adacolumn cytapheresis: a case report - Adacyte\" \/>\n<meta property=\"og:description\" content=\"L Bazzichi&nbsp;1,&nbsp;T Giuliano,&nbsp;A Rossi,&nbsp;A Mazzoni,&nbsp;T Grazzini,&nbsp;F De Feo,&nbsp;C Giacomelli,&nbsp;F Scatena,&nbsp;S Bombardieri, Rheumatol Int. 2008 Jan;28(3):295-7. We report on a female case of rheumatoid arthritis (RA) with hepatitis C virus comorbidity. The patient was treated once weekly over ten consecutive weeks with Adacolumn device. Clinical assessment and HCV-RNA concentration were monitored at weeks-1, 4, 9, 14 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:18:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/\",\"name\":\"Partial remission of refractory RA after Adacolumn cytapheresis: a case report - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2008-07-05T14:55:00+00:00\",\"dateModified\":\"2021-07-09T11:18:04+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Partial remission of refractory RA after Adacolumn cytapheresis: a case report - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/","og_locale":"es_ES","og_type":"article","og_title":"Partial remission of refractory RA after Adacolumn cytapheresis: a case report - Adacyte","og_description":"L Bazzichi&nbsp;1,&nbsp;T Giuliano,&nbsp;A Rossi,&nbsp;A Mazzoni,&nbsp;T Grazzini,&nbsp;F De Feo,&nbsp;C Giacomelli,&nbsp;F Scatena,&nbsp;S Bombardieri, Rheumatol Int. 2008 Jan;28(3):295-7. We report on a female case of rheumatoid arthritis (RA) with hepatitis C virus comorbidity. The patient was treated once weekly over ten consecutive weeks with Adacolumn device. Clinical assessment and HCV-RNA concentration were monitored at weeks-1, 4, 9, 14 [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:18:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/","name":"Partial remission of refractory RA after Adacolumn cytapheresis: a case report - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2008-07-05T14:55:00+00:00","dateModified":"2021-07-09T11:18:04+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/partial-remission-of-refractory-ra-after-adacolumn-cytapheresis-a-case-report\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5631"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}